Category: Acute Respiratory Distress

Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19

Authors: Denise Battaglini, 1 , 2 , 3 Miquéias Lopes-Pacheco, 4 Hugo C. Castro-Faria-Neto, 5 Paolo Pelosi, 1 , 2 and Patricia R. M. Rocco 4 , 6 , 7 , * Front Immunol. 2022; 13: 857573.  Apr 27.  2022 doi: 10.3389/fimmu.2022.857573 PMCID: PMC9091347 PMID: 35572561 Abstract Severe acute respiratory…[...]

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people

Posted on | Posted on John Murphy | Leave a Comment on Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people

Julia Hippisley-Cox1, Duncan Young2,3, Carol Coupland4, Keith M Channon5, Pui San Tan6, David A Harrison7, Kathryn Rowan8,  Paul Aveyard6, Ian D Pavord9, Peter J Watkinson5,10Correspondence to Prof Julia Hippisley-Cox, Primary Care Health Sciences, University of Oxford, Oxford OX1  Abstract…[...]

Here’s what we know so far about the long-term symptoms ofCOVID-19

Posted on | Posted on John Murphy | Leave a Comment on Here’s what we know so far about the long-term symptoms ofCOVID-19

July 26, 2020 3.56pm EDT We’re now all too familiar with the common symptoms of COVID-19: a fever, dry cough and fatigue. Some people also experience aches and pains, a…[...]

How does coronavirus kill? Clinicians trace a ferocious rampage through the body, from brain to toes

Posted on | Posted on John Murphy | Leave a Comment on How does coronavirus kill? Clinicians trace a ferocious rampage through the body, from brain to toes

Authors: By Meredith Wadman, Jennifer Couzin-Frankel, Jocelyn Kaiser, Catherine MatacicApr. 17, 2020 , 6:45 PM On rounds in a 20-bed intensive care unit one recent day, physician Joshua Denson assessed two patients with seizures,…[...]

Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis

Posted on | Posted on John Murphy | Leave a Comment on Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis

Authors: Xinyang Li, Xianrui Zhong, Yongbo Wang, Xiantao Zeng, Ting Luo,Qing Liu  Published: May 3, 2021 AbstractObjectiveWe aimed to systematically identify the possible risk factors responsible for severe cases. MethodsWe…[...]

Coronavirus and the Nervous System

Posted on | Posted on John Murphy | Leave a Comment on Coronavirus and the Nervous System

What is SARS-CoV-2 and COVID-19?What do we know about the effects of SARS-CoV-2 and COVID-19 on the nervous system?What are the immediate (acute) effects of SARS-CoV-2/COVID-19 on the brain?What is…[...]

The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT

Posted on | Posted on John Murphy | Leave a Comment on The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT

Authors: Jia-Ni Zou , Liu Sun , Bin-Ru Wang , You Zou , Shan Xu, Yong-Jun Ding, Li-Jun Shen, Wen-Cai Huang, Xiao-Jing Jiang, Shi-Ming Chen  Published: March 23, 2021 https://doi.org/10.1371/journal.pone.0248957 Abstract The characteristics and…[...]

Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial

Posted on | Posted on John Murphy | Leave a Comment on Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial

Authors: Julio Vallejos, Rodrigo Zoni, María Gabriela Aguirre  Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease…[...]